Dong Hyeon Lee
Overview
Explore the profile of Dong Hyeon Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
194
Citations
1946
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kim G, Jeong S, Jang H, Lee D, Joo S, Kim W
Liver Cancer
. 2024 Aug;
13(4):426-437.
PMID: 39114758
Introduction: This study aimed to investigate the liver-related outcomes of newly suggested metabolic dysfunction-associated steatotic liver disease (MASLD) and MASLD with increased alcohol intake (MetALD), as well as alcohol-associated liver...
12.
Shin W, Lee D, Yoo H, Jung H, Bang M, Kim A
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065735
This study investigated the usage patterns and impact of therapeutic drug monitoring (TDM) for risperidone and paliperidone in patients diagnosed with schizophrenia, utilizing retrospective real-world data sourced from a single...
13.
Magdy A, Kim H, Go H, Lee J, Sohn H, Haam K, et al.
Clin Mol Hepatol
. 2024 Jul;
30(4):824-844.
PMID: 39048522
Background/aims: Blocking the complement system is a promising strategy to impede the progression of metabolic dysfunction-associated steatotic liver disease (MASLD). However, the interplay between complement and MASLD remains to be...
14.
Yoo J, Lee D, Chang Y, Jo H, Cho Y, Lee S, et al.
BMC Public Health
. 2024 Jul;
24(1):1841.
PMID: 38987717
Background: There is a lack of national-level research on alcohol consumption and the epidemiology of alcoholic liver disease (ALD) in South Korea. This study aims to address the critical public...
15.
Park J, Kim Y, Lee M, Kim D, Sim J, Cho K, et al.
J Neurooncol
. 2024 Jun;
169(3):543-553.
PMID: 38907949
Purpose: LLT-1 is a well-known ligand for the natural killer (NK) cell inhibitory receptor NKRP1A. Here, we examined NLRC4 inflammasome components and LLT-1 expression in glioblastoma (GBM) tissues to elucidate...
16.
Kim S, Koh J, Lee D, Kim H, Choi S, Ko Y, et al.
J Hepatol
. 2024 Jun;
81(5):806-818.
PMID: 38879170
Background & Aims: Chronic HCV infection results in abnormal immunological alterations, which are not fully normalized after viral elimination by direct-acting antiviral (DAA) treatment. Herein, we longitudinally examined phenotypic, transcriptomic,...
17.
Im J, Kang W, Lee S, Jeong D, Kim D, Lim M, et al.
Korean J Med Educ
. 2024 Jun;
36(2):189-201.
PMID: 38835311
Purpose: Current faculty development (FD) programs are mostly limited to medical education and often lack a comprehensive and systematic structure. Therefore, the present study aimed to explore the current status...
18.
Lee D, Kim S
J Microbiol
. 2024 May;
62(6):449-461.
PMID: 38814538
Quorum quenching refers to any mechanism that inhibits quorum sensing processes. In this study, quorum quenching activity among bacteria inhabiting riverside soil was screened, and a novel Gram-stain-negative, rod shaped...
19.
Hur M, Lee D, Lee J, Kim M, Park J, Shin H, et al.
Clin Mol Hepatol
. 2024 May;
30(3):500-514.
PMID: 38726505
Background/aims: Chronic hepatitis B (CHB) is related to an increased risk of extrahepatic malignancy (EHM), and antiviral treatment is associated with an incidence of EHM comparable to controls. We compared...
20.
Jeong S, Oh Y, Ahn J, Choi S, Park S, Kim H, et al.
Clin Mol Hepatol
. 2024 May;
30(3):487-499.
PMID: 38711390
Background/aims: To determine the association between evolutionary changes in metabolic dysfunction-associated steatotic liver disease (MASLD) status and the risk of hepatocellular carcinoma (HCC) in a nationwide population-based cohort. Methods: Information...